Keybank National Association Aurinia Pharmaceuticals Inc. Transaction History

Keybank National Association

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$8.95 - $12.8 $47,300 - $67,648	-5,285 Reduced 20.26%	20,800 $209,000
Q1 2022 Apr 28, 2022	SELL	$10.05 - $22.48 $1,417 - $3,169	-141 Reduced 0.54%	26,085 $323,000
Q4 2021 Feb 07, 2022	BUY	$17.78 - $33.08 $178,262 - $331,660	10,026 Added 61.89%	26,226 $600,000
Q1 2021 May 07, 2021	BUY	$12.3 - $18.73 $199,260 - $303,426	16,200 New	16,200 $210,000

208

58.1M

1.14M

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.14B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

Stay updated on Keybank National Association with notifications on news.